Sciele Pharma, Inc. (NASDAQ:SCRX)
31.01
-0 (-0%)
| Sciele Pharma, Inc. (NASDAQ:SCRX) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $31.01 | 52 Week High | $31.21 | ||
| Open | $31.01 | 52 Week Low | $16.89 | ||
| Day High | $31.01 | P/E | 26.73 | ||
| Day Low | $31.01 | EPS | $1.16 | ||
| Volume | 1,079,026 | ||||
| More SCRX Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| NRG | 2 | HLYS | 2 |
| YHOO | 2 | CDNS | 2 |
| DNA | 2 | MSFT | 2 |
| TTWO | 2 | ABI | 2 |
| HLYS | 2 | IVGN | 2 |
| ABI | 2 | MLNM | 2 |
Entities who have mentioned SCRX
- Lehman Brothers | View Related Stories »
- Credit Suisse | View Related Stories »
- Bankruptcy | View Related Stories »
- Needham & Co | View Related Stories »
- Crude Oil | View Related Stories »
- Banc of America | View Related Stories »
- Piper Jaffray | View Related Stories »
- JPMorgan | View Related Stories »
- Scopia Capital | View Related Stories »
- Aurora Capital Group | View Related Stories »
- Roth Capital | View Related Stories »
- Piper Jaffray Alpha List | View Related Stories »
- Cowen & Co | View Related Stories »
- Standard & Poor's | View Related Stories »
- Bear Stearns | View Related Stories »
- Merrill Lynch | View Related Stories »
- Wachovia | View Related Stories »
- Bain Capital | View Related Stories »
- UBS | View Related Stories »
- Wellspring Capital Management | View Related Stories »
- Hellman & Friedman LLC | View Related Stories »
- Barclays | View Related Stories »
- Apollo Management | View Related Stories »
- Top 15 For 2008 | View Related Stories »
- RBC Capital | View Related Stories »
StreetInsider Reports on SCRX by Category
View All BlogsBlogs on SCRX
- Underdog Smallcaps: Potential Short Squeezes
- Eli Lilly's Brewing Battle With Bristol-Myers
- Analyst calls: BP, HD, SOLR, UTX, X, VOD . . .
- Has Lilly's Effient Been FDA Approved?
- Analyst calls: SCRX, GOOG, LOW, DF, GILD, EK, SOLR, XRX ...
Comments on recent SCRX articles
Comments on SCRX
No comments are currently available.
on Jan 2, 2009
at 03:04 PM Despite Lehman failure... Hats off to the Wall Street gurus who pulled off deals despite the carnage for example Teva's successful takeover of Barr was represented by Lehman until the venerable finance house went belly up. Nevertheless the deal close on time.
Article: Top 15 For 2008 (No. 14): M&A Wreckage